Trial intelligence / Profile preview

Hepatic Arterial Oxaliplatin + IV 5-FU/LV for Colorectal Liver Metastases

NCT00006050Phase 2Completed

Sponsor
Unicancer
Start
Apr 1999
Primary completion
Dec 2001
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Unicancer. Started Apr 1999; status: completed.

02

Drugs

oxaliplatin
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00006050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call